Allworth Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.44K | Buy |
607
+234
| +63% | +$2.1K | ﹤0.01% | 3210 |
|
|
2025
Q1 | $3.07K | Hold |
373
| – | – | ﹤0.01% | 3021 |
|
|
2024
Q4 | $2.84K | Hold |
373
| – | – | ﹤0.01% | 3011 |
|
|
2024
Q3 | $2.84K | Hold |
373
| – | – | ﹤0.01% | 2811 |
|
|
2024
Q2 | $2.66K | Sell |
373
-781
| -68% | -$5.58K | ﹤0.01% | 2790 |
|
|
2024
Q1 | $5.86K | Buy |
1,154
+411
| +55% | +$2.09K | ﹤0.01% | 2342 |
|
|
2023
Q4 | $4.45K | Buy |
743
+244
| +49% | +$1.46K | ﹤0.01% | 2323 |
|
|
2023
Q3 | $3.53K | Buy |
499
+220
| +79% | +$1.56K | ﹤0.01% | 2284 |
|
|
2023
Q2 | $1.97K | Buy |
279
+121
| +77% | +$852 | ﹤0.01% | 2494 |
|
|
2023
Q1 | $1.32K | Buy |
158
+38
| +32% | +$317 | ﹤0.01% | 2568 |
|
|
2022
Q4 | $1.38K | Hold |
120
| – | – | ﹤0.01% | 2366 |
|
|
2022
Q3 | $2K | Buy |
120
+108
| +900% | +$1.8K | ﹤0.01% | 2105 |
|
|
2022
Q2 | $0 | Buy |
+12
| New | – | ﹤0.01% | 2398 |
|
|
2018
Q2 | – | Sell |
-500
| Closed | -$2K | – | 940 |
|
|
2018
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 692 |
|
|
2017
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 648 |
|
|
2017
Q3 | $3K | Buy |
+500
| New | +$3K | ﹤0.01% | 622 |
|